Pump thrombosis redux

Journal of Heart and Lung Transplantation

Volumn 34, Issue 12, 2015, Pages 1511-1514

  Stewart, Garrick C ^a   Givertz, Michael M ^a   Mehra, Mandeep R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; DISEASE REGISTRY; DISEASE SURVEILLANCE; FOLLOW UP; GROUPS BY AGE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MORBIDITY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; PROSTHESIS THROMBOSIS; REVIEW; RISK FACTOR; ADVERSE EFFECTS; HEART ASSIST DEVICE; POSTOPERATIVE COMPLICATIONS; THROMBOSIS;

HEART-ASSIST DEVICES; HUMANS; POSTOPERATIVE COMPLICATIONS; THROMBOSIS;

EID: 84949802069     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2015.10.038     Document Type: Editorial

References (24)

1. J.K. Kirklin, D.C. Naftel, F.D. Pagani, and et al. Sixth INTERMACS annual report: a 10,000-patient database J Heart Lung Transplant 33 2014 555 564
2. M.S. Slaughter, F.D. Pagani, E.C. McGee, and et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial J Heart Lung Transplant 32 2013 675 683
3. M.S. Slaughter, J.G. Rogers, C.A. Milano, and et al. Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
4. J.D. Estep, R.C. Starling, D.A. Horstmanshof, and et al. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: results from the ROADMAP study J Am Coll Cardiol 66 2015 1747 1761
5. J.T. Baldwin, and D.L. Mann NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial J Card Fail 16 2010 855 858
6. R.C. Starling, N. Moazami, S.C. Silvestry, and et al. Unexpected abrupt increase in left ventricular assist device thrombosis N Engl J Med 370 2014 33 40
7. J.K. Kirklin, D.C. Naftel, R.L. Kormos, and et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device J Heart Lung Transplant 33 2014 12 22
8. S.S. Najjar, M.S. Slaughter, F.D. Pagani, and et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial J Heart Lung Transplant 33 2014 23 34
9. Organ Procurement and Transplantation Network. Procurement and guidance regarding adult heart status 1A(b) device-related complications. Available at: http://optn.transplant.hrsa.gov/sharedcontentdocuments/guidance-adult-heart-status-device-related-complications.pdf. Accessed November 8, 2015.
10. M.R. Mehra, G.C. Stewart, and P.A. Uber The vexing problem of thrombosis in long-term mechanical circulatory support J Heart Lung Transplant 33 2014 1 11
11. J.A. Cowger, M.A. Romano, P. Shah, and et al. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant J Heart Lung Transplant 33 2014 35 43
12. J.K. Kirklin, D.C. Naftel, F.D. Pagani, and et al. Pump thrombosis in the Thoratec HeartMate II device: an update analysis of the INTERMACS registry J Heart Lung Transplant 2015 in press
13. N.G. Smedira, E.H. Blackstone, J. Ehrlinger, and et al. Current risks of HeartMate II pump thrombosis: non-parametric analysis of INTERMACS data J Heart Lung Transplant 2015 in press
14. N. Jeffries, M.A. Miller, W.C. Taddei-Peters, C. Burke, J.T. Baldwin, and J.B. Young What is the truth behind pump thrombosis in the HeartMate II device: an NHLBI perspective based on Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) data J Heart Lung Transplant 2015 in press
15. F.D. Pagani, C.A. Milano, A.J. Tatooles, and et al. HeartWare HVAD for the treatment of patients with advanced heart failure ineligible for cardiac transplantation: results of the ENDURANCE destination therapy trial J Heart Lung Transplant 34 2015 S9
16. J.M. Stulak, S.M. Dunlay, S. Sharma, and et al. Treatment of device thrombus in the HeartWare HVAD: success and outcomes depend significantly on initial treatment strategy J Heart Lung Transplant 2015 in press
17. PREVENtion of HeartMate II Pump Thrombosis (PREVENT) trial. Available at: https://clinicaltrials.gov/ct2/show/NCT02158403. Accessed November 8, 2015.
18. U.S. Food and Drug Administration. Serious adverse events with implantable left ventricular assist devices (LVADs): FDA safety communication. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm457327.htm. Accessed November 8, 2015.
19. M.M. Givertz Cardiology patient page: ventricular assist devices: important information for patients and families Circulation 124 2011 e305 e311
20. L.A. Allen, L.W. Stevenson, K.L. Grady, and et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association Circulation 125 2012 1928 1952
21. C.R. Bruce, J.S. Blumenthal-Barby, and D. Meyers Benefits and challenges of early introduction of left ventricular assist device placement: a patient-centered perspective J Am Coll Cardiol 66 2015 1762 1765
22. CORI-1310-06998 Trial of a Decision Support Intervention for Patients and Caregivers Offered Destination Therapy Heart Assist Device ((DECIDE-LVAD). Available at: https://clinicaltrials.gov/ct2/show/NCT02344576. Accessed November 8, 2015.
23. I. Netuka, P. Sood, Y. Pya, D. Zimpfer, T. Krabatsch, and J. Garbade Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study J Am Coll Cardiol 66 2015 2579 2589
24. MOMENTUM 3 IDE Clinical Study Protocol (HM3™). Available at: https://clinicaltrials.gov/ct2/show/NCT02224755. Accessed November 8, 2015.